Prostate cancer is a common malignancy among men, and the current screening, imaging and sampling approaches aim to detect early-stage, organ-confined disease.
In such scenario, focal prostate cancer therapy currently relies on the index lesion concept as the dominant lesion that drives the disease natural history. Focal therapy demands the essential imaging and sampling techniques to strategically locate and qualify the disease, but, despite advances in technology, prostate imaging and biopsy have several limitations that need to be overcome if focal therapy is to be developed further. The I Prostate Cancer Focal Treatment International Symposium was convened to foster discussion on this topic that sits at the crossroads of multiple disciplines (Urology, Pathology, Radiology, Radiation Oncology and Medical Oncology) all of which were represented for this comprehensive multidisciplinary review of the current literature.
Written by:
Reis LO, Billis A, Zequi SC, Tobias-Machado M, Viana P, Cerqueira M, Ward JF. Are you the author?
Department of Urology and Pathology, University of Campinas, UNICAMP, Campinas, São Paulo, Brazil.
Reference: Aging Male. 2014 Mar 6. Epub ahead of print.
doi: 10.3109/13685538.2014.895319
PubMed Abstract
PMID: 24597940
UroToday.com Prostate Cancer Section
